AU Patent

AU2014202405B2 — Antiviral therapy

Assigned to ViiV Healthcare Co · Expires 2016-02-25 · 10y expired

What this patent protects

The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in 5 the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/…

USPTO Abstract

The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in 5 the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC. C:\poi\word\SPEC-999969[2].docx

Drugs covered by this patent

Patent Metadata

Patent number
AU2014202405B2
Jurisdiction
AU
Classification
—
Expires
2016-02-25
Drug substance claim
No
Drug product claim
No
Assignee
ViiV Healthcare Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.